Published in Xenotransplantation on July 01, 2005
Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes (2012) 2.17
Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression. Cytotechnology (2015) 0.76
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Free access to Landsat imagery. Science (2008) 4.75
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell (2005) 3.52
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry (2007) 3.35
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med (2007) 2.70
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 2.36
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes (2012) 2.17
Indo-European and Asian origins for Chilean and Pacific chickens revealed by mtDNA. Proc Natl Acad Sci U S A (2008) 2.13
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry (2010) 1.82
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82
Chronic allograft nephropathy: current concepts and future directions. Transplantation (2006) 1.79
The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78
Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest (2010) 1.70
Establishing the validity of domestication genes using DNA from ancient chickens. Proc Natl Acad Sci U S A (2014) 1.69
Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58
Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf (2010) 1.58
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53
Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44
Evaluating the quality of life of patients with restless legs syndrome. Clin Ther (2004) 1.44
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Race-ethnicity and cerebral small vessel disease--comparison between Chinese and White populations. Int J Stroke (2014) 1.41
Antiproliferative effects of low molecular weight heparin. ANZ J Surg (2004) 1.41
The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40
Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation (2014) 1.39
Restless legs syndrome symptomatology, attitudes and beliefs among treated and untreated individuals. Sleep Med (2012) 1.39
Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39
Physician reentry: a concept whose time has come. Obstet Gynecol (2008) 1.38
Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transpl Int (2008) 1.37
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood (2013) 1.34
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.28
Management of primary symptomatic lymphocele after kidney transplantation: a systematic review. Transplantation (2011) 1.27
Cancer after renal transplantation: the next challenge. Am J Transplant (2004) 1.23
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet (2009) 1.21
Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation (2004) 1.20
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev (2010) 1.15
T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol (2003) 1.14
Guiding neuronal development with in situ microfabrication. Proc Natl Acad Sci U S A (2004) 1.13
Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes (2005) 1.11
Is the hippocampus necessary for visual and verbal binding in working memory? Neuropsychologia (2009) 1.10
A biosensor generated via high-throughput screening quantifies cell edge Src dynamics. Nat Chem Biol (2011) 1.09
Changing knowledge, behavior, and practice related to universal precautions among hospital nurses in China. J Contin Educ Nurs (2002) 1.07
Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand. Emerg Infect Dis (2010) 1.06
Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol (2008) 1.06
Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. Transplantation (2013) 1.05
Effectiveness of an HIV/AIDS educational programme for Chinese nurses. J Adv Nurs (2006) 1.04
Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci (2004) 1.03
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther (2007) 1.00
Belatacept for kidney transplant recipients. Cochrane Database Syst Rev (2014) 0.99
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance. Nephrol Dial Transplant (2007) 0.99
Phylogenetic relationships of Australian and New Zealand feral pigs assessed by mitochondrial control region sequence and nuclear GPIP genotype. Mol Phylogenet Evol (2004) 0.97
Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med (2004) 0.97
Multiphoton-excited serotonin photochemistry. Biophys J (2004) 0.97
Delta analysis of posttransplantation tubulointerstitial damage. Transplantation (2004) 0.96
Central implementation strategies outperform local ones in improving HIV testing in Veterans Healthcare Administration facilities. J Gen Intern Med (2013) 0.96
Hypoxia-inducible factor-1α (HIF-1α) potentiates β-cell survival after islet transplantation of human and mouse islets. Cell Transplant (2012) 0.96
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant (2006) 0.95
Characterizing and mapping porcine endogenous retroviruses in Westran pigs. J Virol (2002) 0.94
A lab-on-chip for biothreat detection using single-molecule DNA mapping. Lab Chip (2011) 0.94
Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol (2008) 0.93
High quality genomic DNA extraction from large milk samples. J Dairy Res (2002) 0.93
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Transplantation (2016) 0.92
No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer (2010) 0.92
Cancers after renal transplantation. Transplant Rev (Orlando) (2008) 0.92
Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. Mov Disord (2012) 0.91
A genetic linkage map for the saltwater crocodile (Crocodylus porosus). BMC Genomics (2009) 0.91
Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation (2004) 0.91
Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome. Sleep Med (2011) 0.90
Relationship of causative genetic mutations in maple syrup urine disease with their clinical expression. Mol Genet Metab (2003) 0.90
Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplant (2012) 0.90
Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation (2006) 0.89
Sirolimus: its role in nephrology. Nephrology (Carlton) (2005) 0.88
How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Curr Med Res Opin (2007) 0.88
Quantitative trait loci modifying cardiac atrial septal morphology and risk of patent foramen ovale in the mouse. Circ Res (2006) 0.88
Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation (2008) 0.88
Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Med J Aust (2006) 0.87